Dr. Elkhanany is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1101 Bates Ave
Houston, TX 77030Phone+1 832-355-1000- Is this information wrong?
Summary
- Dr. Ahmed Elkhanany is an oncologist in Houston, TX, and is affiliated with Baylor St. Luke's Medical Center. He received his medical degree from the Alexandria University Faculty of Medicine and has been in practice for five years. He specializes in breast cancer and is experienced in clinical trials, genomics-based translational research, and biological disparities in breast cancer.
Education & Training
University at BuffaloFellowship, Hematology and Medical Oncology, 2016 - 2019
University of Missouri-Kansas City School of MedicineResidency, Internal Medicine, 2013 - 2016
Mayo Clinic College of MedicinePost-Doctoral Fellowship, Breast Cancer Translational Group, 2012 - 2013
Alexandria University Faculty of MedicineClass of 2011
Certifications & Licensure
TX State Medical License 2023 - 2025
AL State Medical License 2019 - 2023
NY State Medical License 2016 - 2018
MO State Medical License 2013 - 2016- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Harvard Business SchoolHealth Care Leadership
Awards, Honors, & Recognition
- Gold Humanism Honor Member Gold Humanism Honor Society, 2015
Clinical Trials
- A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer Start of enrollment: 2018 Dec 07
- Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer Start of enrollment: 2019 Jul 08
- Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer Start of enrollment: 2018 Nov 13
- Join now to see all
Publications & Presentations
PubMed
- Increasing inclusion and equity for Black women in breast cancer clinical trials.Ammanuel Taye, Ahmed Elkhanany, Erica Stringer-Reasor> ;Clinical Advances in Hematology & Oncology. 2024 May 1
- 1 citationsOperational Metrics for the ELAINE 2 Study Combining a Traditional Approach With a Just-in-TIME Model.Sibel Blau, Julio Antonio Peguero, Halle C F Moore, Ian Churchill Anderson, Minal A Barve, Mathew Amprayil Cherian, Ahmed Elkhanany, Ciara Catherine O'Sullivan, Alvaro...> ;JCO Clinical Cancer Informatics. 2023 Jun 1
- 1 citationsMutations in Homologous Recombination Genes and Loss of Heterozygosity Status in Advanced-Stage Breast Carcinoma.Brooke B Bartow, Gene P Siegal, Ceren Yalniz, Ahmed M Elkhanany, Lei Huo, Qingqing Ding, Aysegul A Sahin, Hua Guo, Cristina Magi-Galluzzi, Shuko Harada, Xiao Huang> ;Cancers. 2023 Apr 28
- Join now to see all
Press Mentions
Differences in Immune Cell Environment Help Explain Racial Disparities in Breast CancerJune 5th, 2020
Professional Memberships
- Member
- Member
- Member
Other Languages
- Arabic
Hospital Affiliations
St. Luke's Health - Baylor St. Luke's Medical CenterHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
